Breakthrough Discovery in Gram-Positive Bacteria: Broad-Spectrum Antibacterial Proteins

Research from McMaster University in Hamilton, Canada, has shed new light on the bacterial world, revealing a family of proteins that exhibit broad-spectrum antibacterial activity against a diverse range of target organisms. Known as diffusible antibacterial proteins (ABPs), these enzymes degrade essential cellular components, including DNA, tRNA, and rRNA, ultimately leading to the death of bacteria. Unveiled through a study funded by the Burroughs Wellcome Fund, Canadian Government's Natural Sciences and Engineering Research Council of Canada, New Frontiers in Research Fund, and the European Molecular Biology Organization, this groundbreaking research opens doors to new therapeutic avenues and challenges the conventional understanding of antibiotic production.

Key Takeaways:

  • A family of proteins, diffusible antibacterial proteins (ABPs), has been identified in gram-positive bacteria, exhibiting broad-spectrum antibacterial activity against a diverse range of target organisms.
  • ABPs enzymatically degrade essential cellular components, including DNA, tRNA, and rRNA, leading to bacterial death.
  • Unlike previously characterized bactericidal proteins, ABPs act in a receptor-independent manner, demonstrating a wide range of activity.
  • Target cell entry by ABPs requires proteolytic activation by a cognate, coexported serine protease.
  • The research examined representative ABPs from diverse pathogenic, commensal, and environmental bacteria, revealing broad-spectrum antibacterial activity as a conserved property of this protein family.
  • The study's findings suggest that secreted proteins can act as broad-spectrum antibiotics, indicating the potential for ABPs to serve as a new class of antibiotics.
  • The research has been peer-reviewed and published in the Proceedings of the National Academy of Sciences.

Statistics:

  • The study identified a family of proteins, diffusible antibacterial proteins (ABPs), that exhibit broad-spectrum antibacterial activity against a diverse range of target organisms.
  • 122(43) is the issue number of the Proceedings of the National Academy of Sciences where the study was published.
  • The research was conducted by Stephen R. Garrett, Jake Colautti, and John C. Whitney, with funding from the Burroughs Wellcome Fund, Canadian Government's Natural Sciences and Engineering Research Council of Canada, New Frontiers in Research Fund, and the European Molecular Biology Organization.
  • 2101 Constitution Ave NW is the address of the National Academy of Sciences, the publisher of the Proceedings of the National Academy of Sciences.

Sources:

  • NewsRx. New Gram-Positive Bacteria Findings Has Been Reported by Researchers at McMaster University (Proteolytically activated antibacterial toxins inhibit the growth of diverse gram-positive bacteria). Life Science Weekly. November 4, 2025; p 3207.
  • Proceedings of the National Academy of Sciences. (2025;122(43)).
  • National Academy of Sciences. (www.nasonline.org/)
  • Proceedings of the National Academy of Sciences. (www.nasonline.org/publications/pnas/)
  • McMaster University. Michael DeGroote Institute for Infectious Disease Research.